|Bid||61.89 x 200|
|Ask||61.93 x 100|
|Day's Range||61.91 - 64.68|
|52 Week Range||54.66 - 80.37|
|PE Ratio (TTM)||10.82|
|Forward Dividend & Yield||1.85 (3.06%)|
|1y Target Est||N/A|
CVS (CVS), which is an American retail pharmacy and healthcare company, was the S&P 500’s second-highest performer on April 16. After gaining for three consecutive trading days, CVS opened higher on Monday and surged to four-week high price levels.
Shares of Cardinal Health, McKesson, AmerisourceBergen, Walgreens Boots Alliance and CVS Health all rose on the news.
Generally, companies in the healthcare sector such as Aceto often provide attractive dividend yields due to relatively stable earnings as these are considered defensive sectors that can make money inRead More...
COLUMBUS, Ohio (AP) — A federal judge with an audacious plan to settle hundreds of lawsuits filed by local governments against the drug industry over the destruction wrought by prescription opioid painkillers has altered his course.
The Dividend Aristocrats are high-quality dividend stocks with 25+ years of consecutive dividend increases. They outperformed the SPX with less volatility over time. We asked Ben Reynolds, an income expert and editor of Sure Dividend, and frequent contributor to MoneyShow.com.
Cardinal Health Inc (NYSE: CAH ) showed an improvement in gross margin in its fiscal second-quarter earnings report , and investors should have confidence in the company's ability to drive even more expansion, ...
Let's put Cardinal Health (CAH) stock into this equation and find out if it is a good choice for value-oriented investors right now.
Companies with shares trading at a market price below what they are actually worth, such as Universal Forest Products and Cardinal Health, are deemed undervalued. There’s a few ways youRead More...
Starting in October 2017, Dentsply Sirona (XRAY) implemented a series of management changes with the aim of positioning the company as a stronger and more efficient organization and maintaining the company’s leadership position in dentistry. In October, the company accepted the resignations of Executive Chairman Bret W. Wise, CEO and Director Jeffrey T. Slovin, and President and COO (chief operating officer) Christopher T. Clark. Mark A. Thierer was appointed interim CEO, and Bob Size was appointed interim president and COO. Mark A. Thierer has around 30 years of healthcare industry experience and most recently served as the CEO of OptumRx.
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.